MedTrace Logo

Menopausal Symptoms Probiotic Study

NCT06446869 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2026-01-26

No results posted yet for this study

Summary

In this study, we want to investigate if the active product consisting of a probiotic blend can potentiate the recirculation of active oestrogens into the bloodstream and help to mitigate menopause symptoms, which are closely related to oestrogens levels

Conditions

Interventions

DIETARY_SUPPLEMENT

Gyntima Menopause

Combination of Levilactobacillus brevis KABP-052, Lactiplantibacillus plantarum KABP-051 and Pediococcus acidilactici KABP-021

OTHER

Placebo

Placebo comparator

Sponsors & Collaborators

  • Kaneka Americas Holding Inc.

    collaborator INDUSTRY

  • Community Pharmacology Services Ltd

    lead OTHER

Principal Investigators

  • Kristen Laing, MBChB · Community Pharmacology Services Ltd

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
42 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-10
Primary Completion
2026-07-25
Completion
2026-10-25

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06446869 on ClinicalTrials.gov